Saakshi Medtech & Panels
add_icon

Saakshi Medtech & Panels

178.80
+3.90
(2.23%)
Market Cap
315.69 Cr
PE Ratio
-
Volume
1,60,800.00
Day High - Low
180.95 - 171.10
52W High-Low
217.70 - 118.00
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
315.69 Cr
EPS
2.67
PE Ratio
-
PB Ratio
-
Book Value
55.53
EBITDA
10.90
Dividend Yield
0.00 %
Return on Equity
4.80
Debt to Equity
0.19
Forecast For
Actual
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
2,599.00
#1 74,757.87
22.23
14,846.10
27.62
#1 1,928
118.35
35.02
10,142.00
40,738.71
42.89
#1 18,680.60
15.07
821
19.44
54.40
721.65
32,690.34
24.62
6,652.10
109.76
937
53.45
41.70
193.47
13,394.80
14.96
2,360.30
147.31
369
165.73
43.36
244.10
7,423.36
14.42
2,524.60
98.10
295
147.27
35.53
170.78
6,187.87
14.00
3,459.50
37.06
140
#1 416.84
34.41
904.80
6,038.09
64.73
1,115.20
26.44
63
35.83
36.59
333.65
4,240.86
#1 11.19
2,192.50
99.83
214
143.70
25.13
3,675.10
4,204.39
23.55
639.60
56.11
147
21.55
45.90
1,825.10
3,708.45
23.01
998.10
#1 158.71
159
-
43.77
Growth Rate
Revenue Growth
-24.14 %
Net Income Growth
-58.41 %
Cash Flow Change
-59.79 %
ROE
-60.36 %
ROCE
-58.83 %
EBITDA Margin (Avg.)
-29.77 %

Yearly Financial Results

Annual Financials
2019
2020
2021
2022
2023
2024
2025
TTM
Revenue
38
62
60
92
122
123
93
0
Expenses
34
50
54
76
102
102
82
0
EBITDA
4
12
6
16
21
20
11
0
Operating Profit %
10 %
18 %
10 %
17 %
17 %
16 %
11 %
0 %
Depreciation
1
2
2
2
3
4
4
0
Interest
1
2
2
1
2
2
0
0
Profit Before Tax
2
8
3
13
17
15
7
0
Tax
1
2
1
3
4
4
2
0
Net Profit
2
6
2
9
12
11
5
0
EPS in ₹
61.88
222.60
80.96
7.21
9.52
6.40
2.67
0.00

Balance Sheet

Balance Sheet
2019
2020
2021
2022
2023
2024
2025
Total Assets
39
48
56
65
93
131
131
Fixed Assets
15
23
22
26
34
62
60
Current Assets
21
23
31
37
56
66
54
Capital Work in Progress
2
0
0
0
0
0
13
Investments
0
0
0
0
0
0
0
Other Assets
22
26
34
39
59
69
58
Total Equity & Liabilities
39
48
56
65
93
131
131
Current Liabilities
21
22
27
28
41
21
19
Non Current Liabilities
6
9
9
8
10
17
15
Total Equity
12
18
20
30
42
93
98
Reserve & Surplus
9
15
18
27
40
76
80
Share Capital
3
3
3
3
3
18
18

Cash Flow

Cash Flow
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
-1
2
1
-2
2
12
-12
Investing Activities
-9
-7
-1
-6
-11
-31
-15
Operating Activities
0
11
0
11
11
8
3
Financing Activities
8
-3
2
-7
2
36
-1

Share Holding

% Holding
Sept 2023
Oct 2023
Dec 2023
Mar 2024
Sept 2024
Dec 2024
Mar 2025
Sept 2025
Promoter
73.63 %
73.63 %
73.63 %
73.63 %
73.63 %
73.63 %
73.63 %
73.89 %
FIIs
0.00 %
0.00 %
1.63 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.07 %
0.07 %
3.73 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
11.18 %
11.18 %
17.88 %
22.07 %
22.60 %
22.64 %
22.37 %
20.77 %
Others
15.12 %
15.12 %
3.13 %
4.30 %
3.77 %
3.73 %
4.00 %
5.33 %
No of Share Holders
1,705
1,706
1,358
1,389
1,780
1,985
1,914
1,913

Technical Indicators

RSI(14)
Neutral
38.97
ATR(14)
Less Volatile
6.96
STOCH(9,6)
Neutral
20.11
STOCH RSI(14)
Oversold
2.20
MACD(12,26)
Bearish
-1.85
ADX(14)
Weak Trend
10.77
UO(9)
Bearish
43.23
ROC(12)
Downtrend And Accelerating
-5.51
WillR(14)
Oversold
-83.40